Kemin Industries announced the Food and Drug Administration (FDA) Center for Veterinary Medicine's approval of KemTRACE Chromium, the only chromium propionate as a source of chromium for growing turkeys on the market, at International Production & Processing Expo (IPPE) 2024.
Chromium propionate is highly bioavailable, helps stabilize insulin receptors to improve glucose utilization and reduces the negative effects of stress in animal production.
In preparation for approval, Kemin conducted extensive turkey-specific research.
“Ingredient trials rarely focus specifically on turkey nutrition,” said Dr. Jerry Spears, professor emeritus, North Carolina State University, who worked on research study. "Sharing this news with the turkey industry here at IPPE has been met with excitement.”
The recent study indicated that Kemin’s chromium propionate supplementation can improve turkey performance. This study demonstrated:
- Over an 84-day feeding period, turkeys supplemented with the chromium propionate had greater average daily gain and tended to gain more efficiently than controls.
- It is safe when supplemented in turkey diets at five times the minimal concentration, which enhanced insulin sensitivity.
- Body weights of turkeys supplemented with chromium propionate were heavier than controls by Day 84. (Journal of Poultry Science)
More than 25 years of research and peer-reviewed chromium research studies highlight chromium’s ability to reduce cortisol, which is a hormone secreted in response to stress. The reduction in cortisol during times of stress may decrease negative impacts from stress events, such as extreme heat or cold, diet changes and disease challenges.
Kemin’s chromium propionate is now approved for use in swine, broiler chickens, cattle, horses and growing turkey diets.
